NYU Langone GI Cancer Program Leaders Strengthen Initiative
- NYU langone Health's Perlmutter Cancer Center has announced the establishment of a new Gastrointestinal (GI) Cancer Center, co-directed by Anirban Maitra, MD, and Manuel Hidalgo, MD.
- Anirban Maitra, MD, is recognized globally for his contributions to pancreatic cancer research, notably in early detection.
- Leonard, MD, chief of the Division of Hematology and Medical Oncology at NYU Grossman School of Medicine and director of the Center for Blood Cancers at Perlmutter Cancer...
“`html
NYU Langone Launches New GI Cancer Center with Leading Experts
Table of Contents
Overview
NYU langone Health’s Perlmutter Cancer Center has announced the establishment of a new Gastrointestinal (GI) Cancer Center, co-directed by Anirban Maitra, MD, and Manuel Hidalgo, MD. This initiative aims to accelerate scientific revelation and translate research into improved treatments for patients with GI cancers. The center will integrate multidisciplinary teams of surgical, radiation, and medical oncologists, gastroenterologists, and researchers.
Leadership and expertise
Anirban Maitra, MD, is recognized globally for his contributions to pancreatic cancer research, notably in early detection. Manuel Hidalgo, MD, brings extensive expertise in the development of novel therapies for GI cancers. Both physicians are highly regarded in thier fields and will play a crucial role in shaping the center’s strategic direction.
John P. Leonard, MD, chief of the Division of Hematology and Medical Oncology at NYU Grossman School of Medicine and director of the Center for Blood Cancers at Perlmutter Cancer Center, emphasized the center’s commitment to translating scientific breakthroughs into tangible benefits for patients.
Focus Areas and Integration
The GI Cancer Center will focus on a range of gastrointestinal cancers, including but not limited to:
- Pancreatic Cancer
- Colorectal Cancer
- Esophageal Cancer
- Gastric Cancer
- Hepatobiliary Cancers (liver, gallbladder, bile duct)
A key aspect of the center’s approach is the integration of multidisciplinary teams.This collaborative model will ensure that patients receive thorough, coordinated care tailored to their specific needs. The center will leverage the existing strengths of NYU Langone’s surgical, radiation, and medical oncology departments, and also its gastroenterology and research programs.
Research and Clinical Translation
The center’s mission centers on accelerating the translation of research findings into new treatments. This will involve:
- Conducting cutting-edge research to identify novel therapeutic targets.
- Developing and testing innovative therapies in clinical trials.
- Utilizing advanced technologies,such as genomics and imaging,to personalize treatment strategies.